228 related articles for article (PubMed ID: 34402244)
1. Pre- and Post-Treatment Imaging of Primary Central Nervous System Tumors in the Molecular and Genetic Era.
Ahn SS; Cha S
Korean J Radiol; 2021 Nov; 22(11):1858-1874. PubMed ID: 34402244
[TBL] [Abstract][Full Text] [Related]
2. Updates in the Neuoroimaging and WHO Classification of Primary CNS Gliomas: A Review of Current Terminology, Diagnosis, and Clinical Relevance From a Radiologic Prospective.
Colip C; Oztek MA; Lo S; Yuh W; Fink J
Top Magn Reson Imaging; 2019 Apr; 28(2):73-84. PubMed ID: 31022050
[TBL] [Abstract][Full Text] [Related]
3. Shedding Light on the 2016 World Health Organization Classification of Tumors of the Central Nervous System in the Era of Radiomics and Radiogenomics.
Colen RR; Hassan I; Elshafeey N; Zinn PO
Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):741-749. PubMed ID: 27742114
[TBL] [Abstract][Full Text] [Related]
4. Imaging of Central Nervous System Tumors Based on the 2016 World Health Organization Classification.
Ly KI; Wen PY; Huang RY
Neurol Clin; 2020 Feb; 38(1):95-113. PubMed ID: 31761063
[TBL] [Abstract][Full Text] [Related]
5. Newly Recognized CNS Tumors in the 2021 World Health Organization Classification: Imaging Overview with Histopathologic and Genetic Correlation.
Rigsby RK; Brahmbhatt P; Desai AB; Bathla G; Ebner BA; Gupta V; Vibhute P; Agarwal AK
AJNR Am J Neuroradiol; 2023 Apr; 44(4):367-380. PubMed ID: 36997287
[TBL] [Abstract][Full Text] [Related]
6. Imaging mimics of primary malignant tumors of the central nervous system (CNS).
Anderson MD; Colen RR; Tremont-Lukats IW
Curr Oncol Rep; 2014; 16(8):399. PubMed ID: 24927848
[TBL] [Abstract][Full Text] [Related]
7. The Role of Advanced Brain Tumor Imaging in the Care of Patients with Central Nervous System Malignancies.
Ly KI; Gerstner ER
Curr Treat Options Oncol; 2018 Jun; 19(8):40. PubMed ID: 29931476
[TBL] [Abstract][Full Text] [Related]
8. Current status and quality of radiomics studies in lymphoma: a systematic review.
Wang H; Zhou Y; Li L; Hou W; Ma X; Tian R
Eur Radiol; 2020 Nov; 30(11):6228-6240. PubMed ID: 32472274
[TBL] [Abstract][Full Text] [Related]
9. Primary Central Nervous System Natural Killer Cell Lymphoma in a Chinese Woman with Atypical (11)C-Choline Positron Emission Tomography and Magnetic Resonance Spectrometry Findings.
Li LF; Taw BB; Pu JK; Hwang GY; Lui WM; Leung GK
World Neurosurg; 2015 Oct; 84(4):1176.e5-9. PubMed ID: 26142813
[TBL] [Abstract][Full Text] [Related]
10. Current perspectives in gliomas.
Brock CS; Bower M
Med Oncol; 1997 Jun; 14(2):103-20. PubMed ID: 9330270
[TBL] [Abstract][Full Text] [Related]
11. Primary central nervous system tumors: advances in knowledge and treatment.
Prados MD; Berger MS; Wilson CB
CA Cancer J Clin; 1998; 48(6):331-60, 321. PubMed ID: 9838898
[TBL] [Abstract][Full Text] [Related]
12. [Selected biomarkers in the primary tumors of the central nervous system: short review].
Rychlý B; Grossmann P; Steňo A; Pataky F
Cesk Patol; 2012 Apr; 48(2):65-71. PubMed ID: 22716052
[TBL] [Abstract][Full Text] [Related]
13. Case report of an elderly woman with atypical imaging for primary central nervous system lymphoma who needed a brain biopsy for diagnosis.
Matsuzono K; Yagisawa T; Ohtani K; Ishishita Y; Yamaguchi T; Mashiko T; Ozawa T; Koide R; Tanaka R; Kawai K; Fujimoto S
J Int Med Res; 2021 Aug; 49(8):3000605211035197. PubMed ID: 34461767
[TBL] [Abstract][Full Text] [Related]
14. Use of F-18 FDG PET/CT in non-Hodgkin lymphoma with central nervous system involvement.
Cimarelli S; Sebban C; Thiesse P; Sunyach MP; Blay JY; Ghesquières H
Clin Nucl Med; 2011 Jun; 36(6):e45-9. PubMed ID: 21552016
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphoma.
Miyakita Y; Ohno M; Takahashi M; Kurihara H; Katai H; Narita Y
Jpn J Clin Oncol; 2020 May; 50(5):512-518. PubMed ID: 32129443
[TBL] [Abstract][Full Text] [Related]
16. [
Hovhannisyan N; Fillesoye F; Guillouet S; Ibazizene M; Toutain J; Gourand F; Valable S; Plancoulaine B; Barré L
Theranostics; 2018; 8(16):4563-4573. PubMed ID: 30214639
[TBL] [Abstract][Full Text] [Related]
17. Utility of Preoperative Blood-Oxygen-Level-Dependent Functional MR Imaging in Patients with a Central Nervous System Neoplasm.
Chaudhry AA; Naim S; Gul M; Chaudhry A; Chen M; Jandial R; Badie B
Radiol Clin North Am; 2019 Nov; 57(6):1189-1198. PubMed ID: 31582044
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment Evaluation of Glioma.
Mohammadzadeh A; Mohammadzadeh V; Kooraki S; Sotoudeh H; Kadivar S; Shakiba M; Rasuli B; Borhani A; Mohammadzadeh M
Neuroimaging Clin N Am; 2016 Nov; 26(4):567-580. PubMed ID: 27712794
[TBL] [Abstract][Full Text] [Related]
19. Imaging Advances for Central Nervous System Tumors.
Huang RY; Pope WB
Hematol Oncol Clin North Am; 2022 Feb; 36(1):43-61. PubMed ID: 34563433
[TBL] [Abstract][Full Text] [Related]
20. Primary breast lymphoma sequentially relapsed in the peripheral and central nervous system.
Tang TC; Chang H; Chuang WY
Acta Neurol Belg; 2012 Sep; 112(3):271-4. PubMed ID: 22426680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
